Results 31 to 40 of about 1,604 (182)

Hecken: „Gesetze werden im Treibsand versanden”

Monitor Versorgungsforschung
So selten sich eine schon des Öfteren von Daniela Teichert, der Vorstandsvorsitzenden der AOK Nordost, eingeforderte „Allianz der Willigen“ formiert, so gering wird die Chance sein, dass Robert Habecks „Allianz der Vernünftigen“ die noch ausstehenden ...
Peter Stegmaier
doaj   +1 more source

End-of-life care preferences of older patients with multimorbidity: protocol of a mixed-methods systematic review

BMJ Open, 2020
Introduction End-of-life care is an essential task performed by most healthcare providers and often involves decision-making about how and where patients want to receive care.
Marjan Van Den Akker, Odette Wegwarth, Joerg J Meerpohl, Sharon E Straus, Tammy Hoffmann, Ferdinand M Gerlach, Christine Schmucker, Ana Isabel González-González, Jeanet Blom, Truc Sophia Nguyen, Kristian Röttger, Christiane Muth, Maria-Sophie Brueckle   +12 more
doaj   +1 more source

„Eine Allianz der evidenzbasiert Entscheidenden gegen Populismus“

Monitor Versorgungsforschung
Im Doppel-Titelinterview zum Jahresstart 2024 mit „Monitor Versorgungsforschung“ diskutieren Prof. Josef Hecken, der unparteiische Vorsitzende des Gemeinsamen Bundesausschusses (G-BA), und Univ.-Prof. Dr. med.
Prof. Josef Hecken, Univ.-Prof. Dr. med. Wolfgang Hoffmann, Peter Stegmaier   +2 more
doaj   +1 more source

HTA und aktuelle Herausforderungen: Harmonisierung, Real World Data und Surrogatparameter

GMS Medizinische Informatik, Biometrie und Epidemiologie, 2018
Health Technology Assessment is one of the standard instruments in support of the decision-making to define the public health services both internationally and in the German health care system.
Rüther, Alric, Herrmann, Kirsten H., Hebborn, Ansgar, Perleth, Matthias, Schwarzer, Ruth, Schürmann, Christoph, Sieben, Wiebke, Gillhaus, Johanna, Goertz, Ralf, Jeratsch, Ulli, Leverkus, Friedhelm, Schramm, Wendelin   +11 more
doaj   +1 more source

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer, Eliza J. McEwin, Zhicheng Wang, Joel Lexchin, Barbara Mintzes   +4 more
wiley   +1 more source

Molecular Tumor Boards in Malignant Melanoma: Uncovering Challenges and Opportunities in a Bicenter Retrospective Analysis in Germany

International Journal of Cancer, EarlyView.
Molecular tumor boards (MTB), interdisciplinary teams that use tumor genomic data to guide personalized treatment decisions, have emerged as a promising strategy in melanoma care, although their real‐world clinical impact remains uncertain. This retrospective study evaluated advanced melanoma patients to assess molecularly guided treatment ...
Glenn Geidel, Theresa Lowinus, Patrick Metzger, Rebecca Czurda, Vincent Schipperges, Ulrike Paul, Alessandra Rünger, Julian Kött, Isabel Heidrich, Saskia Lehr, Julia Kühn, Heiko Becker, Cornelius Miething, Martin Werner, Silke Laßmann, Justus Duyster, Tilman Brummer, Ronald Simon, Winfried Alsdorf, Maximilian Christopeit, Carsten Bokemeyer, Kilian Eyerich, Stefan W. Schneider, David Rafei, Melanie Börries, Frank Meiss, Christoffer Gebhardt   +26 more
wiley   +1 more source

„Wächterfunktion im Hinblick auf Qualität und Sicherheit”

Monitor Versorgungsforschung
Einen wahren Parforceritt durch aktuelle Themen der Qualitätssicherung gibt Karin Maag, seit Juli 2021 unparteiisches Mitglied des Gemeinsamen Bundesausschusses, im Interview mit „Monitor Versorgungsforschung”.
Karin Maag, Prof. Dr. Reinhold Roski, Peter Stegmaier   +2 more
doaj   +1 more source

Leveraging EUnetHTA’s conceptual framework to compare HTA decision drivers in France, Italy, and Germany from a manufacturer’s point of view

Health Economics Review, 2018
Background Health Technology Assessments (HTA) procedures differ substantially across the various European countries. We reviewed recent appraisals of a pharmaceutical manufacturer in three major European markets (France; Italy; Germany) and identified ...
Giovanni Giuliani, Frederic Chassagnol, David Traub, Marlene Gyldmark, Ansgar Hebborn, Pierre Ducournau, Jörg Ruof   +6 more
doaj   +1 more source

Predicting psychopathology symptom trajectories using machine learning: a 33‐year prospective study

Journal of Child Psychology and Psychiatry, EarlyView.
Background While previous literature has established a link between psychopathology symptom trajectories and psychosocial risk, most studies have not extended into adulthood or incorporated comprehensive risk measures. We aimed to identify symptom trajectories for externalizing and internalizing symptoms over a 25‐year span and predict them using ...
Seda Sacu, Fabian Streit, Stephanie H. Witt, Tobias Banaschewski, Nathalie E. Holz, Katharina Schultebraucks   +5 more
wiley   +1 more source

Politische Steuerungsprozesse im Politikfeld Gesundheit : eine Analyse der Auswirkung von reguliertem Wettbewerb [PDF]

, 2007
Mit dem "Gesundheitsstrukturgesetz" von 1992 wurden im deutschen System der gesetzlichen Krankenkassen zwei entscheidende Änderungen vorgenommen. Alle Versicherungspflichtigen erhielten ab 1996 die volle Wahlfreiheit bei der Auswahl ihrer gesetzlichen ...
Landmann, Juliane
core